Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

ROSEN, A LONGSTANDING LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMLX

Topics Lawsuit

March 08, 2024

WHY: NEW YORK, NY - (NewMediaWire) - March 08, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) between November...

Lost Money in Amylyx Pharmaceuticals, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Topics Lawsuit

March 08, 2024

From Gibbs Law Group

Via Business Wire

Dow Gains Over 100 Points; AerSale Shares Plunge After Q4 Results ↗

March 08, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dipping around 0.5% on Friday. The Dow traded up 0.27% to 38,894.21 while the NASDAQ fell 0.51% to 16,190.52. The S&P 500...

Via Benzinga

Topics Stocks

Amylyx Stock Crashes 80% After Approved ALS Drug Fails Its Pivotal Test ↗

March 08, 2024

The company could now pull Relyvrio off the market.

Via Investor's Business Daily

Forecasting The Future: 4 Analyst Projections For Amylyx Pharma ↗

March 08, 2024

Via Benzinga

Stocks Fall As Chipmakers Retreat From Highs, Bitcoin Pulls Back After $70,000, Gold Rises To $2,200: What's Driving Markets Friday? ↗

March 08, 2024

The stock market is navigating a mixed closing session this week, with the S&P 500 and Nasdaq 100 struggling to stave off a weekly downturn.

Via Benzinga

Crude Oil Falls Over 1%; Willdan Group Shares Spike Higher ↗

March 08, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 80 points on Friday. The Dow traded up 0.21% to 38,874.05 while the NASDAQ fell 0.42% to 16,204.26. The S&P 500...

Via Benzinga

Topics Stocks

Amylyx Pharmaceuticals (NASDAQ: AMLX) - Kaplan Fox & Kilsheimer LLP Reminds Amylyx Investors of a Class Action Lawsuit and Upcoming Deadline and Encourages Investors with Significant Losses to Contact the Firm

March 08, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

Topics Lawsuit

March 08, 2024

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Via Benzinga

March 08, 2024

NEW YORK, NY - (NewMediaWire) - March 8, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the securities...

Why Is Neurodegenerative Diseases-Focused Amylyx Pharmaceuticals Stock Plunging On Friday? ↗

Topics Lawsuit

9 Health Care Stocks Whale Activity In Today's Session ↗

March 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 08, 2024

Via Benzinga

March 08, 2024

Amylyx Pharmaceuticals' AMX0035 trial results for ALS. Amylyx plans regulatory discussions and potential market actions. AMX0035's ongoing studies in PSP and Wolfram syndrome.

Via Benzinga

Nasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In February ↗

March 08, 2024

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.04% to 38,805.52 while the NASDAQ rose 0.41%...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 08, 2024

Via Benzinga

Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035 in ALS

March 08, 2024

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX

March 07, 2024

From The Rosen Law Firm PA

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx

March 07, 2024

From Faruqi & Faruqi LLP

DEADLINE ALERT: Bernstein Liebhard LLP Reminds Amylyx Pharmaceuticals, Inc. Investors of Upcoming Deadline

March 07, 2024

From Bernstein Liebhard LLP

Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors.

The Top 3 Biotech Stocks to Buy in March 2024 ↗

March 06, 2024

Via InvestorPlace

AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc.

March 04, 2024

From Bernstein Liebhard LLP

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX

March 03, 2024

From The Rosen Law Firm PA

NATIONALLY RANKED ROSEN LAW FIRM Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMLX

March 01, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NATIONALLY RANKED ROSEN LAW FIRM Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMLX

Topics Lawsuit

March 01, 2024

WHY: NEW YORK, NY - (NewMediaWire) - March 01, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) between November...

Kirby McInerney LLP Reminds Amylyx Pharmaceuticals, Inc. (AMLX) Investors of Class Action Filing and Encourages Investors to Contact the Firm

Topics Lawsuit

March 01, 2024

From Kirby McInerney LLP

Via Business Wire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx

March 01, 2024

From Faruqi & Faruqi LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Boeing, Brooge, Cassava, and Amylyx and Encourages Investors to Contact the Firm

February 29, 2024

From Bragar Eagel & Squire

ROSEN, A LEADING LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMLX

February 29, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, A LEADING LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMLX

Topics Lawsuit

February 29, 2024

WHY: NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) between...